Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Indolimine-214 is a metabolite of M. morganii, a bacterium that is increased in the gut microbiome of patients with inflammatory bowel disease (IBD) and colorectal cancer (CRC).1 Indolimine-214 (25 and 100 µg/ml) increases γH2AX levels in HeLa cells and increases the tail DNA percentage in a comet assay using HeLa cells when used at a concentration of 100 µg/ml, both markers of DNA damage, but does not induce DNA damage when used alone in a circular pUC19 plasmid-based genotoxicity assay.
WARNING This product is not for human or veterinary use.
1. Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites. Science 378(6618), eabm3233 (2022).